World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
83
Citations
20550
World Ranking
15796
National Ranking
513

Olivier Fain publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Olivier Fain sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 826 publications — 88th percentile

88% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Olivier Fain D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Olivier Fain sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 83 D-Index — 24th percentile

24% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Olivier Fain is affiliated with Université Paris Cité in France and has contributed extensively to the field of medicine, with a primary focus on rheumatology, genetics, hematology, immunology, and pathology and forensic medicine. Their research work is concentrated in several key topics including coagulation, bradykinin, polyphosphates, and angioedema; otitis media and relapsing polychondritis; systemic lupus erythematosus; vasculitis and related conditions; renal diseases and glomerulopathies; systemic sclerosis and related diseases; and eosinophilic disorders and syndromes.

Their publication record includes numerous papers in prominent journals. Recent papers include:

  • Further characterization of clinical and laboratory features in VEXAS syndrome: large-scale analysis of a multicentre case series of 116 French patients, 2021, British Journal of Dermatology
  • A Phase II prospective trial of azacitidine in steroid-dependent or refractory systemic autoimmune/inflammatory disorders and VEXAS syndrome associated with MDS and CMML, 2022, Leukemia
  • Comparison between idiopathic and VEXAS-relapsing polychondritis: analysis of a French case series of 95 patients, 2022, RMD Open
  • Contribution of rare and predicted pathogenic gene variants to childhood-onset lupus: a large, genetic panel analysis of British and French cohorts, 2020, The Lancet Rheumatology
  • Endometriosis with infertility: A comprehensive review on the role of immune deregulation and immunomodulation therapy, 2020, American Journal of Reproductive Immunology

Fain has published prolifically in several journals, with the most frequent venues being:

  • La Revue de Médecine Interne
  • Annals of the Rheumatic Diseases
  • Lara D. Veeken
  • RMD Open
  • Blood

Their collaborations include frequent co-authors such as:

  • A. Mékinian
  • Pierre Fenaux
  • Vincent Jachiet
  • Delphine Gobert
  • Lionel Adès

Olivier Fain's main fields of study encompass 452 publications in medicine, with significant contributions in the subfields of rheumatology (96 publications), genetics (91 publications), hematology (61 publications), immunology (43 publications), and pathology and forensic medicine (36 publications).

Best Publications

  • Eosinophilic granulomatosis with polyangiitis (Churg‐Strauss): Clinical characteristics and long‐term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort

    Cloé Comarmond;Christian Pagnoux;Mehdi Khellaf;Jean-François Cordier

  • Tolerance and short-term efficacy of rituximab in 43 patients with systemic autoimmune diseases

    JE Gottenberg;L Guillevin;O Lambotte;B Combe

  • Safety and efficacy of rituximab in systemic lupus erythematosus: Results from 136 patients from the French autoimmunity and rituximab registry

    Benjamin Terrier;Zahir Amoura;Philippe Ravaud;Eric Hachulla

  • Vasculitides associated with malignancies: analysis of sixty patients.

    Olivier Fain;Mohamed Hamidou;Patrice Cacoub;Bertrand Godeau

  • Rituximab efficacy and safety in adult splenectomy candidates with chronic immune thrombocytopenic purpura: results of a prospective multicenter phase 2 study

    Bertrand Godeau;Raphael Porcher;Olivier Fain;François Lefrère

  • Intravenous immunoglobulin or high-dose methylprednisolone, with or without oral prednisone, for adults with untreated severe autoimmune thrombocytopenic purpura: a randomised, multicentre trial

    Bertrand Godeau;Sylvie Chevret;Bruno Varet;François Lefrère

  • Anti-HMGCR autoantibodies in European patients with autoimmune necrotizing myopathies: inconstant exposure to statin.

    Yves Allenbach;Laurent Drouot;Aude Rigolet;Jean Luc Charuel

  • Prevalence and incidence of interstitial lung diseases in a multi-ethnic county of Greater Paris

    Boris Duchemann;Isabella Annesi-Maesano;Camille Jacobe de Naurois;Shreosi Sanyal

  • Management of large-vessel vasculitis with FDG-PET: a systematic literature review and meta-analysis.

    Michael Soussan;Patrick Nicolas;Catherine Schramm;Sandrine Katsahian

  • High risk of cancer in autoimmune necrotizing myopathies: usefulness of myositis specific antibody.

    Yves Allenbach;Jeremy Keraen;Anne-Marie Bouvier;Valérie Jooste

  • Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial

    Pierre-Louis Tharaux;Gilles Pialoux;Arthur Pavot;Xavier Mariette

  • Musculoskeletal manifestations of scurvy

    Olivier Fain

  • Rheumatoid arthritis and polymyalgia rheumatica occurring after immune checkpoint inhibitor treatment.

    Rakiba Belkhir;Sébastien Le Burel;Laetitia Dunogeant;Aurélien Marabelle

  • Efficacy of anti-TNF alpha in severe and/or refractory Behçet's disease: Multicenter study of 124 patients

    H Vallet;S Riviere;A Sanna;A Deroux

  • Population‐based prevalence study of Behçet's disease: Differences by ethnic origin and low variation by age at immigration

    Alfred Mahr;Linda Belarbi;Bertrand Wechsler;Dominique Jeanneret

  • Lack of superiority of steroids plus plasma exchange to steroids alone in the treatment of polyarteritis nodosa and Churg-Strauss syndrome. A prospective, randomized trial in 78 patients.

    LOïc Guillevin;Olivier Fain;François Lhote;Bernard Jarrousse

  • Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS Study)

    Nathalie Costedoat-Chalumeau;Lionel Galicier;Lionel Galicier;Olivier Aumaître;Camille Francès

  • Systemic inflammatory and autoimmune manifestations associated with myelodysplastic syndromes and chronic myelomonocytic leukaemia: a French multicentre retrospective study

    Arsène Mekinian;Eric Grignano;Thorsten Braun;Olivier Decaux

  • Outcome of pregnancies in patients with anti-SSA/Ro antibodies: a study of 165 pregnancies, with special focus on electrocardiographic variations in the children and comparison with a control group.

    Nathalie Costedoat-Chalumeau;Zahir Amoura;Jean-Marc Lupoglazoff;Du Le Thi Huong

  • Prevalence of immune-related systemic adverse events in patients treated with anti-Programmed cell Death 1/anti-Programmed cell Death-Ligand 1 agents: A single-centre pharmacovigilance database analysis

    Sébastien Le Burel;Stéphane Champiat;Christine Mateus;Aurélien Marabelle

Frequent Co-Authors

Pierre Fenaux
Pierre Fenaux Université Paris Cité
Patrice Cacoub
Patrice Cacoub Sorbonne University
Lionel Galicier
Lionel Galicier Université Paris Cité
Nathalie Costedoat-Chalumeau
Nathalie Costedoat-Chalumeau Université Paris Cité
Loïc Guillevin
Loïc Guillevin Université Paris Cité
Fabrice Carrat
Fabrice Carrat Sorbonne University
Xavier Mariette
Xavier Mariette University of Paris-Saclay
Olivier Lambotte
Olivier Lambotte University of Paris-Saclay
Eric Hachulla
Eric Hachulla University of Lille
Xavier Puéchal
Xavier Puéchal Université Paris Cité

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering Medicine in the USA opens doors to many other healthcare careers. For those interested in patient care but not eager to take admissions tests like TEAS or HESI, do all nursing schools require the teas is a common question. The answer: several nursing schools now offer programs without these exam requirements, making entry more accessible.

If you are inclined toward leadership roles and hospital management, a degree in healthcare administration can be completed online, allowing you to advance without pausing your current commitments. For registered nurses wanting to become family nurse practitioners, adn to fnp programs can help you bridge your credentials quickly and efficiently.

Interested in preventive medicine or holistic health? Earning a nutrition bachelor degree online can lead to careers in wellness coaching, research, or community health programs. Each of these paths provides flexibility, potential for career advancement, and the satisfaction of making a difference in healthcare.

Best Scientists Citing Olivier Fain

Trending Scientists

Recently Published Articles